DEF 14C: Axil Brands to Reduce Authorized Shares in Corporate Restructuring
Information Statement
Axil Brands is set to decrease its authorized shares of common and preferred stock following approval by a majority of stockholders, aiming to reduce recurring costs.
Summary
- Axil Brands, Inc. is decreasing its authorized shares of common and preferred stock.
- The number of authorized common shares will decrease from 450,000,000 to 15,000,000.
- The number of authorized preferred shares will decrease from 300,000,000 to 28,000,000.
- The number of Series A Preferred shares will decrease from 250,000,000 to 27,773,500.
- The decision was approved by a majority of stockholders via written consent on April 8, 2025.
- The company expects to file the Certificate of Amendment approximately 20 days after mailing the information statement, around April 29, 2025.
- The primary reason for the decrease is to reduce significant recurring costs, mainly Delaware filing fees.
- The Board believes the remaining authorized shares will be sufficient for the company's ongoing capital needs.
- The par value and rights of the existing shares will remain unchanged.
Sentiment
Score: 7
Explanation: The document conveys a neutral to slightly positive sentiment. The action is presented as a cost-saving measure and a streamlining of the company's capital structure. While there are potential risks associated with reduced flexibility, the overall tone is pragmatic and forward-looking.
Positives
- The reduction in authorized shares is expected to decrease recurring costs, primarily filing fees paid to the State of Delaware.
- The Board believes the remaining authorized shares will be sufficient for the company's ongoing share capital needs.
- The par value and rights of the existing shares will remain unchanged, so there is no dilution.
Negatives
- The decrease in authorized shares could limit the company's flexibility to raise capital or make acquisitions in the future, although the company believes the remaining shares are sufficient for its needs.
Risks
- The Certificate of Amendment may be delayed or abandoned if the Board determines it is in the best interests of the company and its stockholders.
- There is no guarantee that the Certificate of Amendment will become effective.
Future Outlook
The Company reserves the right to seek a further increase or decrease in authorized shares from time to time in the future as considered appropriate by the Board.
Management Comments
- The Board believes that it is in the Company's and stockholders' best interests to decrease the number of authorized shares of Common Stock and Preferred Stock in order to reduce significant recurring costs (primarily filing fees paid to the State of Delaware).
- The Board does not anticipate needing to issue the no-longer-authorized shares in the foreseeable future and believes it has continued to reserve a sufficient number of authorized shares of stock following the effectiveness of the Certificate of Amendment to meet the Company's ongoing share capital needs.
Industry Context
Companies periodically adjust their capital structure to optimize costs and maintain flexibility. Reducing authorized shares is a common practice when a company believes it has more shares authorized than it needs for the foreseeable future.
Comparison to Industry Standards
- Many small-cap companies reassess their authorized share count to minimize expenses like Delaware franchise taxes, which are based on the number of authorized shares.
- Similar actions have been taken by companies like [Comparable Company A] and [Comparable Company B] to streamline their capital structure and reduce administrative costs.
- The specific reduction amounts are tailored to each company's individual circumstances and future capital needs.
Stakeholder Impact
- Shareholders may benefit from reduced operating costs.
- The impact on employees, customers, suppliers, and creditors is expected to be minimal.
Next Steps
- File the Certificate of Amendment with the Secretary of State of Delaware approximately 20 days after mailing the information statement.
Key Dates
| Date | Description |
|---|---|
| June 9, 2015 | Date of original Amended and Restated Certificate of Incorporation filing. |
| June 13, 2022 | Date of a Certificate of Amendment filing. |
| January 12, 2024 | Date of a Certificate of Amendment filing. |
| February 12, 2024 | Date of a Certificate of Amendment filing. |
| April 2, 2025 | Date of Schedule 13D/A filing with the SEC by Jeff Toghraie, Intrepid, and Don Frank Nathaniel Vasquez. |
| April 8, 2025 | Record Date for stockholders entitled to notice; date of written consent by majority stockholders and Board approval. |
| April 28, 2025 | Date of the Information Statement. |
| April 29, 2025 (on or about) | Expected date of mailing the Information Statement to stockholders. |
| 20 days following mailing of Information Statement | Expected date of filing the Certificate of Amendment with the Secretary of State of Delaware. |
Keywords
authorized shares, common stock, preferred stock, certificate of amendment, stockholders, filing fees, capital, Axil Brands
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.